Potent MERS-CoV Fusion Inhibitory Peptides Identified from HR2 Domain in Spike Protein of Bat Coronavirus HKU4
Shuai Xia(Shanghai Medical College of Fudan University), Lu Lu(Shanghai Medical College of Fudan University), Zezhong Liu(Ministry of Education), Qiaoshuai Lan(Chinese University of Hong Kong), Shibo Jiang(Shanghai Medical College of Fudan University), Huan Liu(University of Hong Kong), Cong Wang(Xiamen University), Jing Pu(University of New Mexico), Qian Wang(Shanghai Medical College of Fudan University), Wei Xu(Beijing Geriatric Hospital)
Cited by 40
Related Papers
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
|Cell Research|2020|1.4k
Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein
|Cellular and Molecular Immunology|2020|759
Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron
|RePEc: Research Papers in Economics|0|647
Mechanisms and functions of lysosome positioning
|Journal of Cell Science|2016|568
Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor
|Nature Communications|2014|400